Hyperprolactinemia associated with psychotropics--a review
Abstract
Clinicians need to be alert about the potential for hyperprolactinemia and its manifestations with these medications. Prolactin levels need to be monitored and other causes of hyperprolactinemia ruled out in suspected cases.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
Hyperprolactinemia / epidemiology
antidepressive agents / adverse effects
hyperprolactinemia / metabolism
prolactin / blood
psychotropic drugs / therapeutic use
hyperprolactinemia / drug therapy
antipsychotic agents / therapeutic use
antidepressive agents / therapeutic use
hyperprolactinemia / chemically induced*
antipsychotic agents / adverse effects
pmid:20521318
doi:10.1002/hup.1116
subramoniam madhusoodanan
suprit parida
carolina jimenez
anti-anxiety agents / adverse effects
anti-anxiety agents / therapeutic use
mental disorders / drug therapy
prolactin / physiology
psychotropic drugs / adverse effects*
Access
Citation
ID:
272157
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
272157
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet